Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 391

1.

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial.

Collins KA, Ouedraogo A, Guelbeogo WM, Awandu SS, Stone W, Soulama I, Ouattara MS, Nombre A, Diarra A, Bradley J, Selvaraj P, Gerardin J, Drakeley C, Bousema T, Tiono A.

BMJ Open. 2019 Sep 13;9(9):e030598. doi: 10.1136/bmjopen-2019-030598.

PMID:
31519680
2.

IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.

Price MJ, Hicks SL, Bradley JE, Randall TD, Boss JM, Scharer CD.

J Immunol. 2019 Sep 9. pii: ji1900285. doi: 10.4049/jimmunol.1900285. [Epub ahead of print]

PMID:
31501259
3.

Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission.

Mwesigwa J, Slater H, Bradley J, Saidy B, Ceesay F, Whittaker C, Kandeh B, Nkwakamna D, Drakeley C, Van Geertruyden JP, Bousema T, Achan J, D'Alessandro U.

Malar J. 2019 Aug 27;18(1):288. doi: 10.1186/s12936-019-2929-1.

4.

Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017.

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Pannaraj PS, Givner LB, Hulten KG.

Pediatrics. 2019 Sep;144(3). pii: e20190567. doi: 10.1542/peds.2019-0567. Epub 2019 Aug 16.

PMID:
31420369
5.

CYP2D6 polymorphisms and the safety and gametocytocidal activity of single dose primaquine for P. falciparum.

Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, Mustaniemi AL, Eziefula AC, Gosling R, D'Alessandro U, Drakeley C, Niemi M, Bousema T.

Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00538-19. doi: 10.1128/AAC.00538-19. [Epub ahead of print]

6.

Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.

Bradley JS, Roilides E, Broadhurst H, Cheng K, Huang LM, MasCasullo V, Newell P, Stone GG, Tawadrous M, Wajsbrot D, Yates K, Gardner A.

Pediatr Infect Dis J. 2019 Sep;38(9):920-928. doi: 10.1097/INF.0000000000002395.

PMID:
31335570
7.

Analysis of the RIMDAMAL trial.

Bradley J, Moulton LH, Hayes R.

Lancet. 2019 Jul 16. pii: S0140-6736(19)31663-0. doi: 10.1016/S0140-6736(19)31663-0. [Epub ahead of print] No abstract available.

PMID:
31324344
8.

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial.

Bradley JS, Broadhurst H, Cheng K, Mendez M, Newell P, Prchlik M, Stone GG, Talley AK, Tawadrous M, Wajsbrot D, Yates K, Zuzova A, Gardner A.

Pediatr Infect Dis J. 2019 Aug;38(8):816-824. doi: 10.1097/INF.0000000000002392.

PMID:
31306396
9.

Categorising interventions to levels of inpatient care for small and sick newborns: Findings from a global survey.

Moxon SG, Blencowe H, Bailey P, Bradley J, Day LT, Ram PK, Monet JP, Moran AC, Zeck W, Lawn JE.

PLoS One. 2019 Jul 11;14(7):e0218748. doi: 10.1371/journal.pone.0218748. eCollection 2019.

10.

"Reasonable adjustments" under the UK's Equality Act 2010: An enquiry into the care and treatment to patients with intellectual disabilities in acute hospital settings.

Redley M, Lancaster I, Pitt A, Holland A, Thompson A, Bradley JR, Glover G, Thomson K, Jones S, Herbert B, Holme A, Clare ICH.

J Appl Res Intellect Disabil. 2019 Jun 20. doi: 10.1111/jar.12623. [Epub ahead of print]

PMID:
31218787
11.

Reduced mosquito survival in metal-roof houses may contribute to a decline in malaria transmission in sub-Saharan Africa.

Lindsay SW, Jawara M, Mwesigwa J, Achan J, Bayoh N, Bradley J, Kandeh B, Kirby MJ, Knudsen J, Macdonald M, Pinder M, Tusting LS, Weiss DJ, Wilson AL, D'Alessandro U.

Sci Rep. 2019 May 23;9(1):7770. doi: 10.1038/s41598-019-43816-0.

12.

Germline selection shapes human mitochondrial DNA diversity.

Wei W, Tuna S, Keogh MJ, Smith KR, Aitman TJ, Beales PL, Bennett DL, Gale DP, Bitner-Glindzicz MAK, Black GC, Brennan P, Elliott P, Flinter FA, Floto RA, Houlden H, Irving M, Koziell A, Maher ER, Markus HS, Morrell NW, Newman WG, Roberts I, Sayer JA, Smith KGC, Taylor JC, Watkins H, Webster AR, Wilkie AOM, Williamson C; NIHR BioResource–Rare Diseases; 100,000 Genomes Project–Rare Diseases Pilot, Ashford S, Penkett CJ, Stirrups KE, Rendon A, Ouwehand WH, Bradley JR, Raymond FL, Caulfield M, Turro E, Chinnery PF.

Science. 2019 May 24;364(6442). pii: eaau6520. doi: 10.1126/science.aau6520. Epub 2019 May 23.

13.

Untangling the formation and liberation of water in the lunar regolith.

Zhu C, Crandall PB, Gillis-Davis JJ, Ishii HA, Bradley JP, Corley LM, Kaiser RI.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11165-11170. doi: 10.1073/pnas.1819600116. Epub 2019 May 20.

PMID:
31110011
14.

IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.

Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, Rosal-Vela A, Botta D, Bradley JE, Wojciechowski W, Ptacek T, Danila MI, Edberg JC, Bridges SL Jr, Kimberly RP, Chatham WW, Schoeb TR, Rosenberg AF, Boss JM, Sanz I, Lund FE.

Elife. 2019 May 15;8. pii: e41641. doi: 10.7554/eLife.41641.

15.

Comparing the new Ifakara Ambient Chamber Test with WHO cone and tunnel tests for bioefficacy and non-inferiority testing of insecticide-treated nets.

Massue DJ, Lorenz LM, Moore JD, Ntabaliba WS, Ackerman S, Mboma ZM, Kisinza WN, Mbuba E, Mmbaga S, Bradley J, Overgaard HJ, Moore SJ.

Malar J. 2019 Apr 30;18(1):153. doi: 10.1186/s12936-019-2741-y.

16.

Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy.

Winthrop KL, Bingham CO 3rd, Komocsar WJ, Bradley J, Issa M, Klar R, Kartman CE.

Arthritis Res Ther. 2019 Apr 18;21(1):102. doi: 10.1186/s13075-019-1883-1.

17.

Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections.

Larson KB, Patel YT, Willavize S, Bradley JS, Rhee EG, Caro L, Rizk ML.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02578-18. doi: 10.1128/AAC.02578-18. Print 2019 Jun.

PMID:
30962340
18.

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.

Arrieta AC, Sung L, Bradley JS, Zwaan CM, Gates D, Waskin H, Carmelitano P, Groll AH, Lehrnbecher T, Mangin E, Joshi A, Kartsonis NA, Walsh TJ, Paschke A.

PLoS One. 2019 Mar 26;14(3):e0212837. doi: 10.1371/journal.pone.0212837. eCollection 2019.

19.

Evaluation of Aircrew Low-Intensity Threat Laser Eye Protection.

Reddix MD, Funke ME, Kinney MJ, Bradley JL, Irvin G, Rea EJ, Kunkle CK, McCann MB, Gomez J.

Mil Med. 2019 Mar 1;184(Suppl 1):593-603. doi: 10.1093/milmed/usy335.

PMID:
30901431
20.

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT.

Clin Infect Dis. 2019 Mar 5;68(6):895-902. doi: 10.1093/cid/ciy874. No abstract available.

PMID:
30834445

Supplemental Content

Loading ...
Support Center